H.-J. Möller

679 total citations
16 papers, 480 citations indexed

About

H.-J. Möller is a scholar working on Psychiatry and Mental health, Neurology and Clinical Psychology. According to data from OpenAlex, H.-J. Möller has authored 16 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 5 papers in Neurology and 4 papers in Clinical Psychology. Recurrent topics in H.-J. Möller's work include Mental Health and Psychiatry (4 papers), Schizophrenia research and treatment (4 papers) and Functional Brain Connectivity Studies (3 papers). H.-J. Möller is often cited by papers focused on Mental Health and Psychiatry (4 papers), Schizophrenia research and treatment (4 papers) and Functional Brain Connectivity Studies (3 papers). H.-J. Möller collaborates with scholars based in Germany, Sweden and France. H.-J. Möller's co-authors include Thomas Meindl, C. Born, Harald Hampel, Stefan Teipel, Frank Faltraco, Arun L.W. Bokde, M. Rother, Thomas Frodl, Dirk Andreas Zetzsche and Eva Meisenzahl and has published in prestigious journals such as Brain, The British Journal of Psychiatry and Journal of Psychiatric Research.

In The Last Decade

H.-J. Möller

14 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H.-J. Möller Germany	8	250	192	83	70	70	16	480
Carol Tamminga United States	9	127 0.5×	184 1.0×	49 0.6×	100 1.4×	57 0.8×	13	582
C. Stephenson United Kingdom	11	337 1.3×	239 1.2×	90 1.1×	49 0.7×	79 1.1×	15	697
Lahcen Aït Bentaleb Canada	11	184 0.7×	203 1.1×	41 0.5×	28 0.4×	59 0.8×	20	399
Gene E. Alexander United States	8	211 0.8×	271 1.4×	96 1.2×	73 1.0×	211 3.0×	10	461
Dengtang Liu China	15	268 1.1×	258 1.3×	136 1.6×	92 1.3×	48 0.7×	53	640
Jianhua Sheng China	13	203 0.8×	205 1.1×	114 1.4×	76 1.1×	18 0.3×	33	438
Yoshihiro Satomura Japan	14	350 1.4×	208 1.1×	159 1.9×	22 0.3×	35 0.5×	29	604
Stefan Fritze Germany	15	255 1.0×	356 1.9×	159 1.9×	71 1.0×	30 0.4×	41	673
Roberto Limongi Canada	14	274 1.1×	145 0.8×	110 1.3×	17 0.2×	35 0.5×	33	517
Tracy Collier United Kingdom	11	185 0.7×	138 0.7×	41 0.5×	51 0.7×	15 0.2×	18	331

Countries citing papers authored by H.-J. Möller

Since Specialization

Citations

This map shows the geographic impact of H.-J. Möller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.-J. Möller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.-J. Möller more than expected).

Fields of papers citing papers by H.-J. Möller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.-J. Möller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.-J. Möller. The network helps show where H.-J. Möller may publish in the future.

Co-authorship network of co-authors of H.-J. Möller

This figure shows the co-authorship network connecting the top 25 collaborators of H.-J. Möller. A scholar is included among the top collaborators of H.-J. Möller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.-J. Möller. H.-J. Möller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Benninghoff, Jens, Heinz Grunze, Clara K. Schindler, et al.. (2012). Ziprasidone – Not Haloperidol – Induces more de-novo Neurogenesis of Adult Neural Stem Cells Derived from Murine Hippocampus. Pharmacopsychiatry. 46(1). 10–15. 18 indexed citations

Scheuerecker, Johanna, Thomas Frodl, Dirk Andreas Zetzsche, et al.. (2007). Cerebral Differences in Explicit and Implicit Emotional Processing – An fMRI Study. Neuropsychobiology. 56(1). 32–39. 72 indexed citations

Bokde, Arun L.W., Thomas Meindl, C. Born, et al.. (2006). Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. Brain. 129(5). 1113–1124. 206 indexed citations

Schwarz, Markus, Sandra Dehning, Anja Cerovecki, et al.. (2006). P.2.c.030 The COX-2 inhibitor celecoxib has therapeutic effects in major depression:results of a double-blind, placebo controlled, add-on study to reboxetine. European Neuropsychopharmacology. 16. S329–S329. 1 indexed citations

Meisenzahl, Eva, Thomas Frodl, Dirk K. Müller, et al.. (2003). Superior temporal gyrus and P300 in schizophrenia: a combined ERP/structural magnetic resonance imaging investigation. Journal of Psychiatric Research. 38(2). 153–162. 25 indexed citations

Bottlender, Ronald, et al.. (2003). Negative Symptome schizophrener Patienten aus der Perspektive der Psychiater, der Patienten selbst und deren Angehörigen. Der Nervenarzt. 74(9). 762–766. 13 indexed citations

Murck, Harald, H.-J. Möller, & Hans‐Peter Volz. (2002). St. John's wort extract (Ll 160) in somatoform disorders - Results of a placebo-controlled trial. European Neuropsychopharmacology. 12. 342–342. 2 indexed citations

Soyka, Michael, et al.. (2001). Modellprojekt "Qualifizierte ambulante Entgiftung". Der Nervenarzt. 72(7). 565–569. 6 indexed citations

Möller, H.-J., et al.. (2000). Naftidrofuryl in the treatment of vascular dementia (NaVaDe study). European Neuropsychopharmacology. 10. 359–359. 1 indexed citations

10.

Mielke, R., et al.. (1998). Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials.. PubMed. 12 Suppl 2. S29–35. 35 indexed citations

11.

Möller, H.-J.. (1997). Challenges in Vascular Dementia Research. Disease Management & Health Outcomes. 2(Supplement 1). 37–44. 1 indexed citations

12.

Marcusson, Jan, M. Rother, Richard J. Smith, et al.. (1997). A 12-Month, Randomized, Placebo-Controlled Trial of Propentofylline (HWA 285) in Patients with Dementia According to DSM III-R. Dementia and Geriatric Cognitive Disorders. 8(5). 320–328. 65 indexed citations

13.

Gallinat, Juergen, Ulrich Hegerl, & H.-J. Möller. (1996). EEG and event related potentials as indicators of central neurophysiological effects of acamprosate. European Neuropsychopharmacology. 6. S4–134. 1 indexed citations

14.

Höflich, G., Siegfried Kasper, Stephan Ruhrmann, et al.. (1993). Seizure duration and therapeutic efficacy of of ECT in therapy refractory depression. European Neuropsychopharmacology. 3(3). 323–323.

15.

León, Carlos A., et al.. (1990). Care strategies for schizophrenic patients in a transcultural comparison. Comprehensive Psychiatry. 31(5). 398–408. 5 indexed citations

16.

Möller, H.-J., et al.. (1989). The Classification of Functional Psychoses and its Implications for Prognosis. The British Journal of Psychiatry. 154(4). 467–472. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact